Calciject 40 (No.2)

Calciject 40 (No.2) is a veterinary medicine used primarily in cattle to treat hypocalcemia, a metabolic condition caused by insufficient calcium in the bloodstream. Hypocalcemia is common in dairy cows, particularly around calving, when calcium demands increase due to milk production. This calcium deficiency leads to milk fever, also known as parturient paresis, a condition where cows become weak and unable to stand due to low calcium levels. This condition can be life-threatening if not treated promptly.

Milk fever usually manifests within 24-72 hours after calving. As the cow’s body struggles to meet the sudden calcium demands, symptoms such as muscle tremors, lack of appetite, weakness, and depression may develop. In severe cases, it can lead to paralysis, collapse, or even death if untreated. Early detection and rapid calcium supplementation are crucial for the animal’s recovery.

Calciject 40 (No.2) contains calcium borogluconate, a highly bioavailable form of calcium that is quickly absorbed by the body. This allows for rapid correction of the cow’s calcium levels, helping to restore normal muscle function, improve appetite, and alleviate other symptoms of hypocalcemia. In some formulations, Calciject may also include magnesium and phosphorus, which are also important minerals in metabolic recovery.

The product is administered either through intravenous (IV), subcutaneous (under the skin), or intramuscular injection, depending on the severity of the case and the veterinarian’s instructions. IV administration provides the quickest response, making it suitable for severe cases where the animal is unable to stand. In less critical cases, subcutaneous or intramuscular injections may be used to provide a more gradual release of calcium into the bloodstream.

In summary, Calciject 40 (No.2) is an essential treatment for hypocalcemia in dairy cows, helping to prevent the dangerous complications of milk fever and ensuring a swift recovery.